IGC Pharma, Inc (IGC) insider trading

Every open-market stock purchase and sale by IGC Pharma, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: James P Moran (Director), $200K, 2 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent IGC insider trades

DateInsiderTradeValue
Apr 1, 2026Ram Mukunda (CEO)Bought (not open market)—
Apr 1, 2026James P Moran (Director)Bought (not open market)—
Apr 1, 2026Richard K Prins (Director)Bought (not open market)—
Apr 1, 2026Richard K Prins (Director)Bought (not open market)—
Apr 1, 2026Ram Mukunda (CEO)Bought (not open market)—
Apr 1, 2026Claudia Grimaldi (Officer)Bought (not open market)—
Apr 1, 2026Ram Mukunda (CEO)Bought (not open market)—
Apr 1, 2026Ram Mukunda (CEO)Bought (not open market)—
Apr 1, 2026Claudia Grimaldi (Officer)Bought (not open market)—
Apr 1, 2026James P Moran (Director)Bought (not open market)—
Feb 3, 2026Ram Mukunda (CEO)Bought (not open market)—
Feb 3, 2026Ram Mukunda (CEO)Bought (not open market)—
Feb 3, 2026Ram Mukunda (CEO)Bought (not open market)—
Jan 19, 2026Richard K Prins (Director)Bought (not open market)—
Oct 17, 2025Richard K Prins (Director)Bought (not open market)—
Oct 17, 2025Terry L Lierman (Director)Bought (not open market)—
Oct 17, 2025Claudia Grimaldi (Officer)Bought (not open market)—
Oct 17, 2025Claudia Grimaldi (Officer)Bought (not open market)—
Oct 17, 2025Ram Mukunda (CEO)Bought (not open market)—
Oct 17, 2025James P Moran (Director)Bought (not open market)—
Oct 17, 2025Ram Mukunda (CEO)Sold (not open market)—
Oct 17, 2025Ram Mukunda (CEO)Bought (not open market)—
Oct 17, 2025Claudia Grimaldi (Officer)Sold (not open market)—

Who's trading IGC

Get free alerts when an insider at IGC Pharma, Inc files a new trade →